Press Releases

Latest

Tagrisso approved in Japan for 1st-line treatment of EGFR-mutated non-small cell lung cancer
21 August 2018
AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018
20 August 2018
Selumetinib granted orphan designation in Europe for neurofibromatosis type 1
3 August 2018
Imfinzi receives positive EU CHMP opinion for locally-advanced, unresectable non-small cell lung cancer
27 July 2018
H1 2018 Results
26 July 2018
Atacand to be divested to Cheplapharm in Europe
24 July 2018
Lynparza approved in Japan for BRCA-mutated metastatic breast cancer
2 July 2018
Imfinzi approved in Japan for unresectable Stage III non-small cell lung cancer
2 July 2018
Bydureon receives positive EU CHMP opinion for new BCise device for patients with type-2 diabetes
29 June 2018
Lynparza significantly delays disease progression in Phase III 1st-line SOLO-1 trial for ovarian cancer
27 June 2018

Can't find what you are looking for? Our Press Release archive contains all of our press releases dated before 2011 so you should be able to find just what you are looking for.

Explore archive

Contact us

Karen Birmingham

Director Global Science Media

+44 203 749 5634

Rob Skelding

Director Global Media Relations

+44 203 749 5821

Matthew Kent

Director Global Media Relations

+44 203 749 5906

Gonzalo Viña

Director Global Media Relations

+44 203 749 5916

Jennifer Hursit

Manager Global Media Relations

+442037495762

Jacob Lund

Director External Communications, Sweden

+46 8 553 260 20

Lotta Sjösten

Manager Media Relations, Sweden

+46 8 553 271 10

US Media Team

+1 302 885 2677

Press Releases

Contact us

Subscribe

Follow us

LinkedIn